DXRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 34.30%

Insider Buying (Last 12 Months): £68,034.68

Insider Selling (Last 12 Months): £765,000

Diaceutics Insider Trading History Chart

Diaceutics Share Price & Price History

GBX 126.10

▼ -4.9 (-3.74%)

As of 03/13/2025 01:33 PM ET

Days: 30 | 90 | 365

Diaceutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
1/30/2025	Graham Paterson	Insider	Buy	11,643	GBX 138	£16,067.34
1/28/2025	Jordan Clark	Insider	Buy	104	GBX 144	£149.76
9/30/2024	Nick Roberts	Insider	Buy	112	GBX 134	£150.08
8/28/2024	Nick Roberts	Insider	Buy	113	GBX 134	£151.42
6/28/2024	Nick Roberts	Insider	Buy	122	GBX 1	GBX 122
5/22/2024	Graham Paterson	Insider	Buy	39,934	GBX 129	£51,514.86
3/28/2024	Peter Keeling	Insider	Sell	750,000	GBX 102	£765,000
3/6/2024	Graham Paterson	Insider	Buy	33,564	GBX 99	£33,228.36
1/30/2024	Nick Roberts	Insider	Buy	152	GBX 1	GBX 152
10/27/2023	Nick Roberts	Insider	Buy	170	GBX 88	£149.60
8/29/2023	Nick Roberts	Insider	Buy	139	GBX 1	GBX 139
6/5/2023	Nick Roberts	Insider	Buy	21,742	GBX 92	£20,002.64
5/30/2023	Nick Roberts	Insider	Buy	183	GBX 82	£150.06
2/28/2023	Nick Roberts	Insider	Buy	130	GBX 115	£149.50
1/27/2023	Nick Roberts	Insider	Buy	153	GBX 98	£149.94
12/29/2022	Nick Roberts	Insider	Buy	198	GBX 1	GBX 198
10/28/2022	Nick Roberts	Insider	Buy	181	GBX 1	GBX 181
9/9/2022	Nick Roberts	Insider	Buy	161	GBX 93	£149.73
4/6/2022	Deborah Davis	Insider	Buy	5,000	GBX 102	£5,100

See Full Table

SEC Filings (Institutional Ownership Changes) for Diaceutics (LON:DXRX)

52.38% of Diaceutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

Today's Range

Now: GBX 126.10

126

131

50 Day Range

MA: GBX 140.23

126.10

149

52 Week Range

Now: GBX 126.10

151

Volume

104,805 shs

Average Volume

125,560 shs

Market Capitalization

£106.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.58

Who are the company insiders with the largest holdings of Diaceutics?: Diaceutics' top insider investors include:
Graham Paterson (Insider)
Jordan Clark (Insider)
Nick Roberts (Insider)
Peter Keeling (Insider)
Learn More about top insider investors at Diaceutics.